Dave Sampson
Ask VT AI
View News Summary
- Oil prices rise after US-China reach 'very substantial framework' in Kuala Lumpur, setting stage for broader trade deal.
- Novo Nordisk launches a rival $56.50 bid to acquire U.S. obesity biotech Metsera, challenging Pfizer's existing agreement and sparking a bidding war over Metsera's promising GLP-1 pipeline.
- Rangers and Hibernian face off in a crucial midweek fixture, with both teams in good form.
20 days

United States Politics
Discover the latest news, candidates, and key topics of US politics
Ask VT AI
View News Summary
- Oil prices rise after US-China reach 'very substantial framework' in Kuala Lumpur, setting stage for broader trade deal.
- Novo Nordisk launches a rival $56.50 bid to acquire U.S. obesity biotech Metsera, challenging Pfizer's existing agreement and sparking a bidding war over Metsera's promising GLP-1 pipeline.
- Rangers and Hibernian face off in a crucial midweek fixture, with both teams in good form.
20 days

United States Politics
Discover the latest news, candidates, and key topics of US politics
Most Reported By
News from Dave Sampson
News from Dave Sampson
